Approval · Notice of Compliance 11537 · 2010
ETIDROCAL: Notice of Compliance 11537
Issued June 18, 2010
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 11537
- Date
- June 18, 2010
- Company
- Sanis Health Inc.Brampton, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Admin
- Reason
- New manufacturer and product name
- Therapeutic class
- Bone metabolism regulator
- Canadian reference product
- DIDROCAL (Procter & Gamble Pharmaceuticals Canada, Inc)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ETIDROCAL | 02353210 | Cancelled Post Market |
Medicinal ingredients
- ETIDRONATE DISODIUM 400 MG per TAB
- CALCIUM CARBONATE 1,250 MG per TAB